Lin Patrick Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
10
Insider Buys Sum
$245,175.43
Insider Sells Quantity
0
Insider Sells Sum
$0

Insider Activity of Lin Patrick

According to the SEC Form 4 filings, Lin Patrick, being in a position of

  1. Chief Business - Strategy Off at Processa Pharmaceuticals, Inc.,
    оver the last 12 months, has bought 11371 share for $28,455, and sold 0 shares,
    over all time since 2020-10-01, has bought 106621 share for $273,631, and sold 0 shares.

Biography of Lin Patrick

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
 $28,4557100
Sells
 $000

Comparison of Insiders on Amount of Buys and Sells

2026-06-30PurchaseProcessa Pharmaceuticals, Inc.
PCSA
Chief Business - Strategy Off
2,106
0.0934%
$1.93$4,065+5.99%
2026-06-15PurchaseProcessa Pharmaceuticals, Inc.
PCSA
Chief Business - Strategy Off
1,831
0.0812%
$2.22$4,065-8.37%
2026-05-29PurchaseProcessa Pharmaceuticals, Inc.
PCSA
Chief Business - Strategy Off
1,582
0.0701%
$2.57$4,066-19.92%
2026-05-15PurchaseProcessa Pharmaceuticals, Inc.
PCSA
Chief Business - Strategy Off
1,369
0.0606%
$2.97$4,066-30.07%
2026-04-30PurchaseProcessa Pharmaceuticals, Inc.
PCSA
Chief Business - Strategy Off
1,511
0.0677%
$2.69$4,065-22.22%
2026-04-15PurchaseProcessa Pharmaceuticals, Inc.
PCSA
Chief Business - Strategy Off
1,369
0.0606%
$2.97$4,066-28.04%
2026-03-31PurchaseProcessa Pharmaceuticals, Inc.
PCSA
Chief Business - Strategy Off
1,603
0.071%
$2.54$4,064-15.02%
2025-01-27PurchaseProcessa Pharmaceuticals, Inc.
PCSA
Chief Business - Strategy Off
43,500
1.5304%
$0.80$34,691-58.6%
2024-02-01PurchaseProcessa Pharmaceuticals, Inc.
PCSA
Chief Business - Strategy Off
1,500
0.065%
$2.40$3,600-32.48%
2024-01-31PurchaseProcessa Pharmaceuticals, Inc.
PCSA
Chief Business - Strategy Off
2,500
0.1069%
$2.37$5,925-33.05%
2022-05-17PurchaseProcessa Pharmaceuticals, Inc.
PCSA
Chief Business - Strategy Off
2,000
0.0106%
$1.59$3,189+4.23%
2022-04-06PurchaseProcessa Pharmaceuticals, Inc.
PCSA
Chief Business - Strategy Off
2,000
0.0132%
$3.29$6,587-31.88%
2021-12-14PurchaseProcessa Pharmaceuticals, Inc.
PCSA
Chief Business - Strategy Off
3,000
0.0194%
$4.00$12,000-25.06%
2021-12-03PurchaseProcessa Pharmaceuticals, Inc.
PCSA
Chief Business - Strategy Off
3,500
0.023%
$4.80$16,795-35.56%
2021-08-26PurchaseProcessa Pharmaceuticals, Inc.
PCSA
Chief Business - Strategy Off
4,000
0.0257%
$6.02$24,088-41.06%
2021-06-21PurchaseProcessa Pharmaceuticals, Inc.
PCSA
Chief Business - Strategy Off
2,000
0.0124%
$6.65$13,300-29.11%
2020-10-01PurchaseProcessa Pharmaceuticals, Inc.
PCSA
Chief Business - Strategy Off
31,250
0.2732%
$4.00$125,000+13.69%
Total: 17
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsInsider RatioList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.